Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction. In April, FDA finalized two guidance documents to speed up development of NGS-based tests.
In the quest for faster, more accurate results, these products will have a tremendous impact on diagnosing infectious diseases.
Held in November, the COMPAMED and MEDICA trade fair will showcase futuristic as well as tried-and-true medical technologies.
Research around the global is focusing on a faster, more precise approach in diagnostics.
A new technology from Nanomix is targeting fast detection to expedite patient treatment and improve outcomes.
The deal will further cement the company’s competitive advantage in providing ‘comprehensive musculoskeletal healthcare’.
Medtech manufacturers are taking advantage of this global opportunity.
There are concerns over the accuracy of direct-to-consumer tests.
Technology that quickly and accurately diagnoses cancer will be in high demand in the coming years.
The increase in communicable diseases is elevating competition in the device arena.